In a world in which both medical diagnostics and therapies are shifting towards minimally invasive technologies, it is not surprising that steadily increasing non-dilutive funding is available for innovative medical device companies.

The scope of funding support covers the entire R&D cycle, from early stage exploratory and discovery work all the way to late stage clinical research and validation.

In this webinar we will present the latest trends at the NIH and the new available funding opportunities with respect to medical devices.

In this webinar Ayal Ronen, FreeMind’s VP will discuss:

  • Trends in medical device non-dilutive funding
  • Cross section analysis of different opportunities available
  • The NIBIB – The national institute of Biomedical Imaging and Bioengineering
  • Challenges
  • How to maximize chances for success

Medical+Device_Webinar – Click to download PDF

The Biomedical Advanced Research and Development Authority (BARDA) develops and purchases the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies.

Interestingly, between 2010 and 2012, BARDA experienced a budget increase of some 60% from $337.5M to roughly $547M. For Life Science organizations, this translates into hundreds of millions of dollars in potential grants and contracts to be awarded.

In the upcoming webinar in the series of summer educational webinars, FreeMind’s VP, Ayal Ronen, will discuss key opportunities within BARDA available for Life Science organizations.

Specifically Mr. Ronen will cover:

  • BARDA overview – mission and goals
  • Interesting statistics on BARDA funding
  • Specific funding opportunities
  • Regulations, limitations and major challenges in applying
  • How to maximize chances for award

BARDA_Webinar – Click to download PDF

FreeMind is proud to host the Michael J. Fox Foundation on the upcoming summer educational webinar focusing on Parkinson’s and other Neurological disorders.

Parkinson’s is a complex disease that varies greatly among affected individuals. For The Michael J. Fox Foundation, there is one clear measure of success: delivering patients better treatments and, ultimately, a cure for Parkinson’s disease. Today, MJFF is the largest private funder of Parkinson’s research in the world.

FreeMind Group has been successful in the past few years in securing non-dilutive funding for Parkinson’s & CNS related research for industry and academia from government agencies and private foundations alike.

In this webinar Ayal Ronen, FreeMind’s VP and Tracey Mumford, Associate Director, Research Partnerships will discuss:

  • Upcoming program deadlines
  • Awards, regulations applying, requirements and limitations
  • MJFF Priority Focus Areas
  • Parkinson’s Research & CNS Funding Opportunities from different mechanisms
  • The challenges in putting together a complex and large scale application
  • How to maximize chances for success
  • Industry & academia collaboration

MJFF_Webinar – Click to donwload PDF

Assembling a budget for your grant is typically the last item to be addressed. Reason being that the figures you are suggesting must reflect the work you are proposing to complete.

That said, simply stating the cost per item is hardly enough, and a properly constructed justification is mandatory and weighs heavily on approval of your budget.

When comprising the budget one must ensure an accurate completion of the document while adhering to NIH guidelines and stipulations. Items such as indirect costs, sub-contractors, sub-awards, salaries, and even travel expenses must be completed correctly. This becomes increasingly difficult when large and complex applications have several budgets feeding into one.

In this webinar Ayal Ronen, FreeMind’s VP will discuss:

  • Budget: Know the limits
  • Facilities & Administration rate
  • Modular or detailed: which to use?
  • Allowable costs
  • Direct vs. Indirect
  • Final tips

Budget Webinar – Click to download PDF

FreeMind’s VP Ayal Ronen will discuss the SBIR/STTR program viewed by many as a critical source of funding for the Small Business Life Science community.

Through the SBIR/STTR program some $700,000,000 are awarded annually by the NIH specifically to research project grants. Despite a continuous decline in success rates, this remains a crucial path small businesses must explore on a regular basis to secure funding for their product development efforts.

Specifically Mr Ronen will discuss:

  • SBIR/STTR rules and regulations
  • Leveraging your SBIR/STTR award to large scale funding opportunities
  • Industry – Academia collaboration
  • Process for applying, requirements and limitations
  • How to maximize chances for success!

SBIR Webinar – Click to Download PDF